UPDATE 1-FDA staff raises safety issues over Trevena opioid injection
October 09, 2018 at 09:16 AM EDT
Trevena Inc's opioid injection to treat acute pain could be abused and potentially lead to overdose, staff reviewers of the U.S. Food and Drug Administration said on Tuesday, sending the drugmaker's shares down 66 percent.